TIDES USA is North America’s annual, leading conference on oligonucleotide, peptide, mRNA, genome editing, and drug delivery therapeutics, covering discovery, development, and commercialization. Our event provides a platform for scientists, researchers, and industry professionals to share insights, showcase innovations, and address challenges in the field.

TIDES USA will take place on May 11-14, 2026, at the Hynes Convention Center in Boston, Massachusetts.

TIDES USA is ideal for:

• Scientists and researchers working in oligonucleotide, mRNA and peptide therapeutics.
• Professionals involved in drug discovery, development and commercialization.
• Experts in analytical development, manufacturing and delivery technologies.
• Industry leaders seeking to network and collaborate on cutting-edge solutions.

TIDES refers to Therapeutic Innovations in Drug Engineering and Synthesis, focusing on peptides and oligonucleotides as emerging therapeutic modalities in the pharmaceutical industry. These molecules are highly versatile and precise, making them valuable for targeting a wide range of diseases, including diabetes, cancer, osteoporosis, cardiovascular conditions, genetic disorders, and rare diseases.TIDES represents a growing area of innovation in drug development, offering new possibilities for treating complex and previously untreatable conditions.

Our event typically attracts more than 1,900 scientists, executives, engineers, and decision-makers in oligonucleotide, peptide, mRNA, genome editing, and therapeutic delivery sectors.

TIDES USA covers the latest advances across oligonucleotide, peptide, mRNA and genome-editing therapeutics, including:

• Discovery, preclinical and clinical development of oligonucleotides and peptides

• Chemistry, manufacturing and controls (CMC) and scalable production strategies

• mRNA therapeutics, vaccines and genome-editing technologies

• Drug delivery innovations for complex biomolecules

• Analytical, regulatory and quality considerations across modalities

• Real-world case studies and emerging trends shaping next-generation therapeutics

Definitely! Attendees can connect through poster sessions, exhibit halls, dedicated networking breaks, and one-on-one meetings.

No, TIDES USA is part of a broader series of TIDES events run by Informa Connect, including:

• TIDES USA – Boston, US: Focused on oligonucleotide, peptide, mRNA, genome editing, and drug delivery therapeutics.
• TIDES Europe – Vienna, Austria: Covers European innovations in oligonucleotide and peptide therapeutics, clinical development, and regional regulatory insights.
• TIDES Asia – Tokyo, Japan: Highlights advances in oligonucleotide and peptide discovery, preclinical research, and therapeutic delivery across the Asia-Pacific region.